Patient-reported outcomes (PROs) comprise measures that reflect patient perspectives and evaluations, including assessments of constructs such as quality of life, symptoms and experiences with care. Considerable evidence demonstrates that PRO ratings from patients and observers, including clinicians, are not equivalent, and that the patient’s rating provides distinct information that can only come from the experience of undergoing cancer therapies. PROs can play a crucial role in clinical trials.